首页>
外国专利>
RECOMBINANT PLASMID DNA pHIASP03, ENCODING HYBRID PROTEIN WITH HUMAN PROINSULIN Aspart, CELL Escherichia coli TRANSFORMED BY RECOMBINANT PLASMID DNA pHIAsp03, AND STRAIN OF BACTERIA Escherichia coli JM109/pHIAsp03 - PRODUCER OF HYBRID PROTEIN WITH HUMAN PROINSULIN Aspart
RECOMBINANT PLASMID DNA pHIASP03, ENCODING HYBRID PROTEIN WITH HUMAN PROINSULIN Aspart, CELL Escherichia coli TRANSFORMED BY RECOMBINANT PLASMID DNA pHIAsp03, AND STRAIN OF BACTERIA Escherichia coli JM109/pHIAsp03 - PRODUCER OF HYBRID PROTEIN WITH HUMAN PROINSULIN Aspart
FIELD: biotechnology.;SUBSTANCE: invention is a recombinant plasmid DNA pHIAsp03, directing the synthesis of human hybrid protein with human proinsulin Aspart containing DNA encoding the hybrid protein with human proinsulin Aspart with size of 134 amino-acid residue with the amino acid sequence shown in Figure 2, comprising the amino acid sequence of the leader peptide in the form of N-terminal fragment of human gamma-interferon, connected to proinsulin Aspart with the peptide linker. On the basis of the recombinant plasmid pHIAsp03 the strain Escherichia coli JM109/pHIAsp03 was obtained - producer of the hybrid protein with proinsulin Aspart, registered in the federal state unitary enterprise State Research Institute of Genetics RNCIM under the number B-11411.;EFFECT: use of the claimed inventions enables to simplify the technology of isolation of insulin Aspart and to increase its yield.;4 cl, 2 dwg, 2 ex
展开▼
机译:领域:本发明是一种重组质粒DNA pHIAsp03,指导人类杂种蛋白与人胰岛素原阿斯巴特的合成,其包含编码与人胰岛素原阿斯巴特杂种的DNA,其具有134个氨基酸残基,其氨基酸序列如图所示在图2中,其包含人γ-干扰素的N末端片段形式的前导肽的氨基酸序列,其通过肽接头与胰岛素原天冬氨酸连接。在重组质粒pHIAsp03的基础上,获得了大肠杆菌JM109 / pHIAsp03菌株-带有原胰岛素Aspart的杂合蛋白的生产商,该蛋白在联邦国立统一企业State Institute of Genetics RNCIM中注册,编号为B-11411。使用要求保护的发明能够简化Aspart胰岛素的分离技术并提高其收率。4cl,2 dwg,2 ex
展开▼